Global Clinical Trial Imaging Service Market Research Report 2023

Publication ID:

PB502234879

Publication Date:

February 28, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.
Highlights
The global Clinical Trial Imaging Service market was valued at US$ 1495.2 million in 2022 and is anticipated to reach US$ 2281.9 million by 2029, witnessing a CAGR of 7.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core clinical trial imaging manufacturers include ICON, ERT, McLaren etc.The top 5 companies hold a share about 40%.North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 27% and 27%.In terms of product, central imaging service is the largest segment, with a share about 70%. And in terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging Service.
The Clinical Trial Imaging Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clinical Trial Imaging Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Imaging Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bioclinica
Parexel International Corporation
Icon
Biomedical Systems Corporation (ERT)
Biotelemetry
Cardiovascular Imaging Technologies
Intrinsic Imaging
Ixico
Radiant Sage
Worldcare Clinical
Micron, Inc
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Imaging Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Imaging Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 In-house Imaging Service
1.2.3 Central Imaging Service
1.3 Market by Application
1.3.1 Global Clinical Trial Imaging Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Medical Device Manufacturers
1.3.5 Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Imaging Service Market Perspective (2018-2029)
2.2 Clinical Trial Imaging Service Growth Trends by Region
2.2.1 Global Clinical Trial Imaging Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial Imaging Service Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trial Imaging Service Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trial Imaging Service Market Dynamics
2.3.1 Clinical Trial Imaging Service Industry Trends
2.3.2 Clinical Trial Imaging Service Market Drivers
2.3.3 Clinical Trial Imaging Service Market Challenges
2.3.4 Clinical Trial Imaging Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Imaging Service Players by Revenue
3.1.1 Global Top Clinical Trial Imaging Service Players by Revenue (2018-2023)
3.1.2 Global Clinical Trial Imaging Service Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trial Imaging Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Imaging Service Revenue
3.4 Global Clinical Trial Imaging Service Market Concentration Ratio
3.4.1 Global Clinical Trial Imaging Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Imaging Service Revenue in 2022
3.5 Clinical Trial Imaging Service Key Players Head office and Area Served
3.6 Key Players Clinical Trial Imaging Service Product Solution and Service
3.7 Date of Enter into Clinical Trial Imaging Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Imaging Service Breakdown Data by Type
4.1 Global Clinical Trial Imaging Service Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trial Imaging Service Forecasted Market Size by Type (2024-2029)
5 Clinical Trial Imaging Service Breakdown Data by Application
5.1 Global Clinical Trial Imaging Service Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trial Imaging Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Imaging Service Market Size (2018-2029)
6.2 North America Clinical Trial Imaging Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Clinical Trial Imaging Service Market Size by Country (2018-2023)
6.4 North America Clinical Trial Imaging Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Imaging Service Market Size (2018-2029)
7.2 Europe Clinical Trial Imaging Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Clinical Trial Imaging Service Market Size by Country (2018-2023)
7.4 Europe Clinical Trial Imaging Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Imaging Service Market Size (2018-2029)
8.2 Asia-Pacific Clinical Trial Imaging Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Clinical Trial Imaging Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Trial Imaging Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Imaging Service Market Size (2018-2029)
9.2 Latin America Clinical Trial Imaging Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Clinical Trial Imaging Service Market Size by Country (2018-2023)
9.4 Latin America Clinical Trial Imaging Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Imaging Service Market Size (2018-2029)
10.2 Middle East & Africa Clinical Trial Imaging Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Clinical Trial Imaging Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Trial Imaging Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioclinica
11.1.1 Bioclinica Company Detail
11.1.2 Bioclinica Business Overview
11.1.3 Bioclinica Clinical Trial Imaging Service Introduction
11.1.4 Bioclinica Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.1.5 Bioclinica Recent Development
11.2 Parexel International Corporation
11.2.1 Parexel International Corporation Company Detail
11.2.2 Parexel International Corporation Business Overview
11.2.3 Parexel International Corporation Clinical Trial Imaging Service Introduction
11.2.4 Parexel International Corporation Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.2.5 Parexel International Corporation Recent Development
11.3 Icon
11.3.1 Icon Company Detail
11.3.2 Icon Business Overview
11.3.3 Icon Clinical Trial Imaging Service Introduction
11.3.4 Icon Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.3.5 Icon Recent Development
11.4 Biomedical Systems Corporation (ERT)
11.4.1 Biomedical Systems Corporation (ERT) Company Detail
11.4.2 Biomedical Systems Corporation (ERT) Business Overview
11.4.3 Biomedical Systems Corporation (ERT) Clinical Trial Imaging Service Introduction
11.4.4 Biomedical Systems Corporation (ERT) Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.4.5 Biomedical Systems Corporation (ERT) Recent Development
11.5 Biotelemetry
11.5.1 Biotelemetry Company Detail
11.5.2 Biotelemetry Business Overview
11.5.3 Biotelemetry Clinical Trial Imaging Service Introduction
11.5.4 Biotelemetry Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.5.5 Biotelemetry Recent Development
11.6 Cardiovascular Imaging Technologies
11.6.1 Cardiovascular Imaging Technologies Company Detail
11.6.2 Cardiovascular Imaging Technologies Business Overview
11.6.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Service Introduction
11.6.4 Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.6.5 Cardiovascular Imaging Technologies Recent Development
11.7 Intrinsic Imaging
11.7.1 Intrinsic Imaging Company Detail
11.7.2 Intrinsic Imaging Business Overview
11.7.3 Intrinsic Imaging Clinical Trial Imaging Service Introduction
11.7.4 Intrinsic Imaging Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.7.5 Intrinsic Imaging Recent Development
11.8 Ixico
11.8.1 Ixico Company Detail
11.8.2 Ixico Business Overview
11.8.3 Ixico Clinical Trial Imaging Service Introduction
11.8.4 Ixico Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.8.5 Ixico Recent Development
11.9 Radiant Sage
11.9.1 Radiant Sage Company Detail
11.9.2 Radiant Sage Business Overview
11.9.3 Radiant Sage Clinical Trial Imaging Service Introduction
11.9.4 Radiant Sage Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.9.5 Radiant Sage Recent Development
11.10 Worldcare Clinical
11.10.1 Worldcare Clinical Company Detail
11.10.2 Worldcare Clinical Business Overview
11.10.3 Worldcare Clinical Clinical Trial Imaging Service Introduction
11.10.4 Worldcare Clinical Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.10.5 Worldcare Clinical Recent Development
11.11 Micron, Inc
11.11.1 Micron, Inc Company Detail
11.11.2 Micron, Inc Business Overview
11.11.3 Micron, Inc Clinical Trial Imaging Service Introduction
11.11.4 Micron, Inc Revenue in Clinical Trial Imaging Service Business (2018-2023)
11.11.5 Micron, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Bioclinica
Parexel International Corporation
Icon
Biomedical Systems Corporation (ERT)
Biotelemetry
Cardiovascular Imaging Technologies
Intrinsic Imaging
Ixico
Radiant Sage
Worldcare Clinical
Micron, Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂